Clinical trials
Phase 3 Neoplasm Metastasis trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2010 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Terminated | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Novartis Pharmaceuticals | 3 |
| Pfizer | 3 |
| Amgen | 2 |
| Eli Lilly and Company | 2 |
| ARCAGY/ GINECO GROUP | 1 |
| AbbVie | 1 |
| Alaunos Therapeutics | 1 |
| Celcuity Inc | 1 |
| Mirati Therapeutics Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 24 |
| Breast Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Carcinoma | 3 |
| Neoplasms | 3 |
| Carcinoma, Renal Cell | 2 |
| Endometrial Neoplasms | 2 |
| Blood Protein Disorders | 1 |
| Bone Diseases | 1 |
| Bone Marrow Diseases | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.